| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Association between triglyceride-glucose index and gastric carcinogenesis: a health checkup cohort study
|
Kim, Young Min
|
|
|
25 |
1 |
p. 33-41
|
artikel
|
| 2 |
Brain metastases in gastroesophageal cancers—an underestimated complication
|
Brunner, Marius
|
|
|
25 |
1 |
p. 161-169
|
artikel
|
| 3 |
CircTMC5 promotes gastric cancer progression and metastasis by targeting miR-361-3p/RABL6
|
Xu, Peng
|
|
|
25 |
1 |
p. 64-82
|
artikel
|
| 4 |
Correction to: Association between triglyceride-glucose index and gastric carcinogenesis: a health checkup cohort study
|
Kim, Young Min
|
|
|
25 |
1 |
p. 42-43
|
artikel
|
| 5 |
Correction to: DLX6-AS1/miR-204-5p/OCT1 positive feedback loop promotes tumor progression and epithelial–mesenchymal transition in gastric cancer
|
Liang, Yu
|
|
|
25 |
1 |
p. 297-298
|
artikel
|
| 6 |
Correction to: Real-world safety and effectiveness of nivolumab in Japanese patients with unresectable advanced or recurrent gastric/gastroesophageal junction cancer that has progressed after chemotherapy: a postmarketing surveillance study
|
Yamaguchi, Kensei
|
|
|
25 |
1 |
p. 254
|
artikel
|
| 7 |
Development of a predictive model for extragastric recurrence after curative resection for early gastric cancer
|
Bae, Jae Seok
|
|
|
25 |
1 |
p. 255-264
|
artikel
|
| 8 |
Exploration of predictors of benefit from nivolumab monotherapy for patients with pretreated advanced gastric and gastroesophageal junction cancer: post hoc subanalysis from the ATTRACTION-2 study
|
Kang, Yoon-Koo
|
|
|
25 |
1 |
p. 207-217
|
artikel
|
| 9 |
Genomic landscape of a mouse model of diffuse-type gastric adenocarcinoma
|
Zhang, Menghua
|
|
|
25 |
1 |
p. 83-95
|
artikel
|
| 10 |
Glucose metabolic profiles evaluated by PET associated with molecular characteristic landscape of gastric cancer
|
Bae, Seong-Woo
|
|
|
25 |
1 |
p. 149-160
|
artikel
|
| 11 |
Hypoxia associated lncRNA HYPAL promotes proliferation of gastric cancer as ceRNA by sponging miR-431-5p to upregulate CDK14
|
Piao, Hai-yan
|
|
|
25 |
1 |
p. 44-63
|
artikel
|
| 12 |
Insertion–deletion rate is a qualitative aspect of the tumor mutation burden associated with the clinical outcomes of gastric cancer patients treated with nivolumab
|
Kim, Hyung-Don
|
|
|
25 |
1 |
p. 226-234
|
artikel
|
| 13 |
Insulin and the insulin receptor collaborate to promote human gastric cancer
|
Saisana, Marina
|
|
|
25 |
1 |
p. 107-123
|
artikel
|
| 14 |
Integrin β1 orchestrates the abnormal cell-matrix attachment and invasive behaviour of E-cadherin dysfunctional cells
|
Figueiredo, Joana
|
|
|
25 |
1 |
p. 124-137
|
artikel
|
| 15 |
Interdisciplinary insights into the link between gut microbiome and gastric carcinogenesis—what is currently known?
|
Kaźmierczak-Siedlecka, Karolina
|
|
|
25 |
1 |
p. 1-10
|
artikel
|
| 16 |
Molecular classification of gastric cancer predicts survival in patients undergoing radical gastrectomy based on project HOPE
|
Furukawa, Kenichiro
|
|
|
25 |
1 |
p. 138-148
|
artikel
|
| 17 |
Nationwide cohort study: cholesterol level is inversely related with the risk of gastric cancer among postmenopausal women
|
Lim, Joo Hyun
|
|
|
25 |
1 |
p. 11-21
|
artikel
|
| 18 |
New response evaluation criteria using early morphological change in imatinib treatment for patients with gastrointestinal stromal tumor
|
Ishida, Tomo
|
|
|
25 |
1 |
p. 218-225
|
artikel
|
| 19 |
Pembrolizumab versus paclitaxel for previously treated PD-L1-positive advanced gastric or gastroesophageal junction cancer: 2-year update of the randomized phase 3 KEYNOTE-061 trial
|
Fuchs, Charles S.
|
|
|
25 |
1 |
p. 197-206
|
artikel
|
| 20 |
Phase II study of S-1 and oxaliplatin as neoadjuvant chemotherapy for locally advanced adenocarcinoma of the gastric or esophagogastric junction: KSCC1601
|
Iwatsuki, Masaaki
|
|
|
25 |
1 |
p. 180-187
|
artikel
|
| 21 |
Radiological criteria for selecting candidates for neoadjuvant chemotherapy for gastric cancer: an exploratory analysis from the PRODIGY study
|
Kim, Hyung-Don
|
|
|
25 |
1 |
p. 170-179
|
artikel
|
| 22 |
Real-world effectiveness of nivolumab in advanced gastric cancer: the DELIVER trial (JACCRO GC-08)
|
Takahashi, Yoshikazu
|
|
|
25 |
1 |
p. 235-244
|
artikel
|
| 23 |
Real-world safety and effectiveness of nivolumab in Japanese patients with unresectable advanced or recurrent gastric/gastroesophageal junction cancer that has progressed after chemotherapy: a postmarketing surveillance study
|
Yamaguchi, Kensei
|
|
|
25 |
1 |
p. 245-253
|
artikel
|
| 24 |
Remission of type 2 diabetes after gastrectomy for gastric cancer: diabetes prediction score
|
Kwon, Yeongkeun
|
|
|
25 |
1 |
p. 265-274
|
artikel
|
| 25 |
Risk factors and oncological impact of positive resection margins in gastrectomy for cancer: are they salvaged by an additional resection?
|
Muneoka, Yusuke
|
|
|
25 |
1 |
p. 287-296
|
artikel
|
| 26 |
Sex differences in tumor characteristics, treatment, and outcomes of gastric and esophageal cancer surgery: nationwide cohort data from the Dutch Upper GI Cancer Audit
|
Kalff, Marianne C.
|
|
|
25 |
1 |
p. 22-32
|
artikel
|
| 27 |
Synergistic effects of Rapamycin and Fluorouracil to treat a gastric tumor in a PTEN conditional deletion mouse model
|
Zhu, Cong-hui
|
|
|
25 |
1 |
p. 96-106
|
artikel
|
| 28 |
Three-year outcomes of a randomized phase III trial comparing adjuvant chemotherapy with S-1 plus docetaxel versus S-1 alone in stage III gastric cancer: JACCRO GC-07
|
Kakeji, Yoshihiro
|
|
|
25 |
1 |
p. 188-196
|
artikel
|
| 29 |
Trends in clinical outcomes and long-term survival after robotic gastrectomy for gastric cancer: a single high-volume center experience of consecutive 2000 patients
|
Choi, Seohee
|
|
|
25 |
1 |
p. 275-286
|
artikel
|
Tijdschrift beschrijving